Michael is a medical device entrepreneur and investor who serves on the boards of 11 emerging medical device companies. He is a co-founder and board member of Aetherworks, Apnex, Benechill, BridgePoint, Conceptx and Sage Medical. He is an investor and board member of Coaxia, Lutonix, Pharmacentra, Transoma and UltraShape. In addition he was a co-founder and board member of Velocimed which was sold to St. Jude Medical in 2005.

Michael was born and grew up in Ithaca (his father was a Professor of Music at Ithaca College). After receiving his BS ILR he moved to Israel where he was promptly unemployed or underemployed for the better part of two years. From 1981-84 he worked in Labor Relations for Baxter Inc. in Ashdod, Israel. During this time his wife Judy (VanAdelsberg — Cornell, 1979) completed her PhD at the Weizman Institute in Israel. In 1986 Michael received his MBA from Cornell.

In 1986 Michael joined Scimed Life Systems, a late stage start up company in Minneapolis, as a product manager. Scimed grew to be a leader in the field of interventional cardiology (balloon angioplasty catheters, stents etc). Michael led marketing at Scimed until 1995 when the company merged with Boston Scientific. From 1995-2000 Michael served as the President of the Cardiology division of Boston Scientific. When he left Boston Scientific in 2000, the Cardiology division had revenue of $1.4 billion and over 4000 employees.

Judy is a McKnight Distinguished Professor of Genetics, Cell Biology and Development at the University of Minnesota. They have two sons, Oren (23, Cornell, 2008) and Noah (18).

Michael has held leadership roles with numerous philanthropic organizations including the American Heart Association, the Minneapolis Jewish Federation and Minneapolis Jewish Day School. His violin playing was a casualty of fatherhood; BUT in the last few years he has run four marathons.

At the time of our 35th reunion, Michael continues his work with emerging medical companies — over the past 5 years he has exited BridgePoint Medical (sold to Boston Scientific) and Lutonix (sold to CR Bard), co-founded Rebiotix, the leading Microbiome transplant company and joined the boards of a handful of promising start ups. He is spending the majority of his time in Israel. His wife Judith is a professor of Molecular Microbiology at Tel Aviv University.

At the time of our 40th reunion, Michael & Judith have moved to Tel Aviv where he continues to invest in and work with early stage medical companies. He recently exited Rebiotix (sold to Ferring Pharmaceuticals) and Mazor Robotics (sold to Medtronic). Most importantly Michael and Judith's granddaughter, Nina, is now 4 years old.